Menu Search
Equities

Perseus Proteomics Inc

4882:TYO

Perseus Proteomics Inc

Actions
  • Price (JPY)609.00
  • Today's Change-9.00 / -1.46%
  • Shares traded541.20k
  • 1 Year change+32.97%
  • Beta1.2085
Data delayed at least 20 minutes, as of Nov 08 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Perseus Proteomics Inc had net income fall 40.34% from a loss of 787.00m to a larger loss of 1.10bn despite a 6.58% increase in revenues from 94.20m to 100.40m. An increase in the selling, general and administrative costs as a percentage of sales from 307.65% to 364.94% was a component in the falling net income despite rising revenues.
Gross margin87.73%
Net profit margin-934.32%
Operating margin-944.87%
Return on assets-41.36%
Return on equity-46.33%
Return on investment-43.27%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at Perseus Proteomics Inc fell by 903.52m. Cash Flow from Financing totalled 63.94m or 63.69% of revenues. In addition the company used 833.90m for operations while cash used for investing totalled 150.34m.
Cash flow per share-74.62
Price/Cash flow per share--
Book value per share134.05
Tangible book value per share134.05
More ▼

Balance sheet in JPYView more

Perseus Proteomics Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio19.95
Quick ratio19.91
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.